Real-world budget impact of fidaxomicin versus vancomycin or metronidazole for in-hospital treatment of clostridioides difficile infection

HIGHLIGHTS

• who: Laura Whitney et al. from the George`s University Hospitals NHS Foundation Trust, London , QT, UK have published the Article: Real-World Budget Impact of Fidaxomicin versus Vancomycin or Metronidazole for In-Hospital Treatment of Clostridioides difficile Infection, in the Journal: Antibiotics 2023, 106 of /2023/
• what: The aim of this study was to compare the cost-effectiveness and impact of fidaxomicin versus vancomycin or metronidazole for treating CDI in a realworld UK setting. The authors report the results of this analysis.
• how: This analysis only considered mortality on the first decision . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.